| Bluebird Bio, Inc.. (10/9/19). "Press Release: Bluebird Bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases". Cambridge, MA & Bagsvaerd. |
2019-10-09 |
| Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments". Halle (Saale). |
2019-10-08 |
| Blueprint Genetics Oy. (10/2/19). "Press Release: Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness Launch an Open Access Program for Patients with Inherited Retinal Disease in the United States". |
2019-10-02 |
| Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London. |
2019-09-30 |
| Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". |
2019-09-24 |
| H. Lundbeck A/S. (9/20/19). "Press Release: Lundbeck and Takeda Announce Ministry of Health, Labour and Welfare (MHLW) Approval of Trintellix in Japan". |
2019-09-20 |
| Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. |
2019-09-18 |
| H. Lundbeck A/S. (9/16/19). "Press Release: Lundbeck to Acquire Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention – in a Transaction Valued at up to USD 1.95 Billion Net of Cash". Valby & Bothell, WA. |
2019-09-16 |
| Lytix Biopharma AS. (9/12/19). "Press Release: Lytix Biopharma AS Appoints Øystein Rekdal as the new CEO". |
2019-09-12 |
| Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel. |
2019-09-11 |
| Genmab A/S. (9/9/19). "Press Release: Genmab and Tempus Enter into Strategic Collaboration Agreement". Copenhagen. |
2019-09-09 |
| Sigrid Therapeutics AB. (9/5/19). "Press Release: Stockholm-based Technology Startup Sigrid Therapeutics, Developing SiPore15 – a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to |
2019-09-05 |
| Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. |
2019-09-04 |
| Boehringer Ingelheim. (9/3/19). "Press Release: Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/Glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes". Ingelheim & Copenhagen. |
2019-09-03 |
| RhoVac AB. (9/2/19). "Press Release: RhoVac Optimizes the Structure of the Management Team and Appoints Anders Månsson as New CEO". |
2019-09-02 |
| Novartis AG. (8/30/19). "Press Release: Novartis Ofatumumab Demonstrates Superiority versus Aubagio in Two Head-to-head Phase III Multiple Sclerosis Studies". Basel. |
2019-08-30 |
| Unibio International plc. (8/28/19). "Press Release: Unibio Completes USD 15 M (GBP 12.4 M) Financing Round". London & Copenhagen. |
2019-08-28 |
| Nanovi A/S. (8/27/19). "Press Release: Nanovi Raises New Capital". Copenhagen. |
2019-08-27 |
| AstraZeneca plc. (8/22/19). "Press Release: AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi". |
2019-08-22 |
| RhoVac AB. (8/22/19). "Press Release: RhoVac AB Has Been Granted 2.5 Million Euro from Horizon 2020". |
2019-08-22 |
| Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund. |
2019-08-20 |
| H. Lundbeck A/S. (8/14/19). "Press Release: Lundbeck Appoints New EVP, People & Communication". Valby. |
2019-08-14 |
| High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". |
2019-08-08 |
| Novozymes A/S. (8/8/19). "Press Release: Change to the Executive Leadership Team". Bagsvaerd. |
2019-08-08 |
| Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London. |
2019-08-05 |
| Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. |
2019-08-05 |
| ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". |
2019-08-02 |
| Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. |
2019-07-31 |
| Alligator Bioscience AB. (7/31/19). "Press Release: Alligator Bioscience Regains Global Rights from Janssen to CD40 Agonistic Antibody, ADC-1013 (JNJ-64457107)". Lund. |
2019-07-31 |
| Cytena GmbH. (7/23/19). "Press Release: Cytena Founds Subsidiary in Taiwan". Freiburg. |
2019-07-23 |
| Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. |
2019-07-19 |
| Genmab A/S. (7/19/19). "Press Release: Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering". Copenhagen. |
2019-07-19 |
| Genmab A/S. (7/12/19). "Press Release: Genmab and Blink Biomedical Enter into Commercial License Agreement". Copenhagen. |
2019-07-12 |
| Nanoform Finland Ltd.. (7/10/19). "Press Release: Nanoform Appoints Director of Investor Relations Following International Growth". Helsinki. |
2019-07-10 |
| Genedata AG. (7/9/19). "Press Release: Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations". Basel. |
2019-07-09 |
| IGM Biosciences, Inc.. (7/8/19). "Press Release: IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline". |
2019-07-08 |
| [iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com
& Life-Sciences-Scandinavia.com". Bremen. |
2019-07-08 |
| Cobo Technologies ApS. (7/5/19). "Press Release: CRISPR Researchers to Benefit from Cobo Technologies and Sciex Partnership". Copenhagen. |
2019-07-05 |
| Nanoform Finland Ltd.. (7/3/19). "Press Release: Nanoform Continues Strategic Growth with €10 Million Private Placement". Helsinki. |
2019-07-03 |
| Bayer AG. (7/2/19). "Press Release: Leo Pharma Completes the Acquisition of Bayer’s Prescription Dermatology Business". Ballerup & Leverkusen. |
2019-07-02 |
| ExpreS2ion Biotech Holding AB. (7/1/19). "Press Release: ExpreS2ion Licenses Groundbreaking CRISPR/Cas9 Gene Editing Technology from ERS Genomics". |
2019-07-01 |
| Photocure ASA. (7/1/19). "Press Release: Photocure and Asieris Enter into a Global Licensing Deal for Cevira with up to USD 250 Million in Milestones and Double-digit Royalties". Oslo. |
2019-07-01 |
| [iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. |
2019-07-01 |
| Storm Therapeutics Ltd.. (6/27/19). "Press Release: Storm Therapeutics Appoints Dr John Haurum to the Board of Directors". Cambridge. |
2019-06-27 |
| Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. |
2019-06-26 |
| Quanterix Corporation. (6/26/19). "Press Release: Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier". Billerica, MA. |
2019-06-26 |
| Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. |
2019-06-25 |
| Vesalius Biocapital Partners Sàrl. (6/25/19). "Press Release: Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund". Strassen, Luxembourg. |
2019-06-25 |
| MGI Tech Co., Ltd.. (6/20/19). "Press Release: MGI Forms Partnership with Karolinska Institutet Centre for Translational Microbiome Research (CTMR) to Understand the Effects of Microbiome on Human Health". Shenzhen. |
2019-06-20 |
| Genovis AB. (6/19/19). "Press Release: Genovis AB Hires CFO". |
2019-06-19 |
| Spero Therapeutics, Inc.. (6/13/19). "Press Release: Spero Announces $10 Million Registered Direct Offering of Common Stock. Novo Holdings A/S through Its Novo REPAIR Impact Fund to Invest Up to $10 million". Cambridge, MA. |
2019-06-13 |
| Agilent Technologies Inc.. (6/11/19). "Press Release: Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)". Santa Clara, CA. |
2019-06-11 |
| Saga Diagnostics AB. (6/11/19). "Press Release: Saga Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies". Lund & Oslo. |
2019-06-11 |
| Sprint Bioscience AB. (6/11/19). "Press Release: Sprint Bioscience Appoints Jessica Martinsson as Acting CEO after CEO Anders Åberg Announces His Resignation". |
2019-06-11 |
| Genmab A/S. (6/11/19). "Press Release: Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody-CD38". Copenhagen. |
2019-06-11 |
| Calliditas Therapeutics AB. (6/10/19). "Press Release: Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore". |
2019-06-10 |
| Lunaphore Technologies S.A.. (6/10/19). "Press Release: Cartana, Lunaphore and Stockholm University Collaborate on Automated Next Generation In Situ Sequencing". Stockholm & Lausanne. |
2019-06-10 |
| Themis Bioscience GmbH. (6/4/19). "Press Release: CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development". Vienna & Oslo. |
2019-06-04 |
| Biotage AB. (6/4/19). "Press Release: Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications". Uppsala. |
2019-06-04 |
| Leo Pharma A/S. (6/3/19). "Press Release: Leo Pharma Appoints Catherine Mazzacco as New CEO". Ballerup. |
2019-06-03 |
| [iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme |
2019-05-30 |
| H. Lundbeck A/S. (5/29/19). "Press Release: Lundbeck Closes Acquisition of Abide Therapeutics". Valby. |
2019-05-29 |
| Oxford BioMedica plc. (5/28/19). "Press Release: Oxford BioMedica Announces Strategic Investment by Novo Holdings A/S". Oxford. |
2019-05-28 |
| Biotage AB. (5/24/19). "Press Release: Tomas Blomquist – New CEO & President of Biotage". Uppsala. |
2019-05-24 |
| Genovis AB. (5/16/19). "Press Release: Genovis Signs Distribution Agreement with Fujifilm Wako Pure Chemical for Japan, Taiwan and Singapore Markets". |
2019-05-16 |
| Illumina, Inc.. (5/15/19). "Press Release: Illumina Files Patent Infringement Suit against BGI in Denmark". San Diego, CA. |
2019-05-15 |
| Symphogen A/S. (5/15/19). "Press Release: Symphogen Announces New Capital Raise and Explores Strategic Options". |
2019-05-15 |
| Mobidiag Oy. (5/14/19). "Press Release: Investment Plan for Europe – Mobidiag Secures EUR 25 million from EIB". |
2019-05-14 |
| SensID GmbH. (5/14/19). "Press Release: SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards". Göteborg & Rostock. |
2019-05-14 |
| Forschungszentrum Jülich. (5/10/19). "Press Release: Alzheimer Therapy from Jülich Passes another Important Test. Drug Candidate PRI-002 Has Successfully Completed Phase I of Clinical Research". Jülich & Vienna. |
2019-05-10 |
| H. Lundbeck A/S. (5/6/19). "Press Release: Lundbeck to Acquire Abide Therapeutics, Adding a Unique Discovery Platform and a Lead Compound in an Exploratory Phase IIa Program for Tourette’s". Valby & San Diego, CA. |
2019-05-06 |
| Genedata AG. (5/2/19). "Press Release: Out-of-the-Box Integration of Genedata Bioprocess with MODDE Streamlines Bioprocess Development DOE". Basel. |
2019-05-02 |
| Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. |
2019-04-27 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Reaches New Milestone – Now more than 9,900 European Life Science Deals Available at Life-Sciences-Europe.com". Bremen. |
2019-04-26 |
| Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen". |
2019-04-23 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. |
2019-04-17 |
| Cobo Technologies ApS. (4/15/19). "News: Cobo Technologies Member of NIST Genome Editing Consortium, US". |
2019-04-15 |
| Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd. |
2019-04-12 |
| Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). |
2019-04-09 |
| Gesynta Pharma AB. (4/4/19). "Press Release: Gesynta Pharma Secures 6 MEUR for Development Programs in Financing Round Led by Industrifonden". Solna. |
2019-04-04 |
| Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. |
2019-04-02 |
| Illumina, Inc.. (3/29/19). "Press Release: Illumina Files Patent Infringement Suit against BGI in Germany". San Diego, CA. |
2019-03-29 |
| Enamine Ltd.. (3/26/19). "Press Release: Enamine Extends Multi-year Drug Discovery Collaboration with Lundbeck". Kiev. |
2019-03-26 |
| Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". |
2019-03-26 |
| Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London. |
2019-03-21 |
| NeoPhore Ltd.. (3/20/19). "Press Release: NeoPhore Appoints Dr John Haurum as Non-Executive Director. Former F-star CEO Joins the Board of Directors". |
2019-03-20 |
| Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge. |
2019-03-12 |
| Olink Proteomics. (3/12/19). "Press Release: Summa Equity Acquires Olink Proteomics". |
2019-03-12 |
| Modus Therapeutics AB. (3/11/19). "Press Release: Modus Therapeutics Strengthens Management Team with Appointment of Mats Blom, MBA as CFO". Stockholm. |
2019-03-11 |
| Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. |
2019-03-11 |
| Snipr Biome ApS. (3/11/19). "Press Release: Snipr Biome Raises $50 Million Series A Financing to Advance CRISPR-based Microbiome Drugs to Human Clinical Trials". Copenhagen. |
2019-03-11 |
| H. Lundbeck A/S. (3/8/19). "Press Release: Lundbeck Appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer". Valby. |
2019-03-08 |
| Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma Announces Once-weekly TransCon Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency". |
2019-03-04 |
| Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma A/S Announces Proposed Public Offering of ADSs". Copenhagen. |
2019-03-04 |
| CureVac AG. (2/27/19). "Press Release: CEPI Awards US$ 34m Contract to CureVac to Advance the RNA Printer—a Disruptive, Transportable mRNA Vaccine Manufacturing Platform that Can Rapidly Combat Multiple Diseases". Oslo. |
2019-02-27 |
| Mobidiag Oy. (2/25/19). "Press Release: Mobidiag Signs Multiple International Agreements for Distribution of Its Amplidiag and Novodiag Diagnostic Solutions". |
2019-02-25 |
| Follicum AB. (2/11/19). "Press Release: Follicum Selects Novel Peptide Drug Candidate for the Treatment of Diabetes and Protection of Beta Cells". |
2019-02-11 |
| Follicum AB. (2/4/19). "Press Release: Follicum’s New Topical Formulation of FOL-005 Results in Increased Hair Growth on a Par with Leading Commercial Product". |
2019-02-04 |
| MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. |
2019-01-31 |
| Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. |
2019-01-30 |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo-2019.png){kind=logo}
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
Date
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
